Document Detail


Systematic evaluation of vascular access by color-Doppler ultrasound decreased the incidence of emergent vascular access intervention therapy and x-ray exposure time: a single-center observational study.
MedLine Citation:
PMID:  22458397     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Arteriovenous fistula has superior patency over other accesses, but vascular access intervention therapy (VAIVT) for stenosis or thrombosis still remain major reasons for hospital admission of dialysis patients. The aim of this study was to examine the usefulness of systematic evaluation of vascular access by color-Doppler ultrasound (CDUS). This study was a single-center observational design study. We planned screening CDUS to evaluate all vascular accesses once per year, and additionally, follow-up CDUS of post-interventional patients 1 month, 3 months and 6 months after their recent VAIVT. This systematic evaluation was started from September 2009. The observational period between September 2008 and August 2009 was defined as period A. The observational period between September 2009 and August 2010 was defined as period B. We compared the incidence of emergent VAIVT and X-ray exposure time during the period A to B. 131 patients with AV fistula were assigned. 13 patients were excluded due to death, hospital transfer or re-operation of their accesses. During period A, 57 VAIVTs were carried out, and 37 cases (65%) were emergent. During period B, 42 VAIVTs were carried out, and 11 cases (25%) were emergent. The incidence of emergent intervention therapy was lower during period B than period A (P < 0.001). The amount of X-ray exposure time per patient was decreased in patients who received VAIVT during both periods (P < 0.03). Systematic evaluation of vascular access by CDUS decreased the incidence of emergent VAIVT and X-ray exposure time.
Authors:
Satoshi Matsui; Kentaro Nakai; Tomohiko Taniguchi; Takahiro Nagai; Takafumi Yokomatsu; Yutaka Kono; Tetsu Mizoguchi; Shinji Miki; Akira Yoshida; Kazuhiro Nagao; Hiroko Tsuji; Shinji Ono
Related Documents :
16044057 - Successful treatment of refractory recurrent vaginal candidiasis with cetirizine plus f...
6396117 - Comparative clinical trial of bifonazole solution versus selenium sulphide shampoo in t...
7841427 - Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational,...
6396247 - A new topical antifungal drug: tioconazole.
22232307 - Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutritio...
24291407 - Similar outcome despite slight clinical differences between lumbar radiculopathy induce...
Publication Detail:
Type:  Journal Article     Date:  2012-01-05
Journal Detail:
Title:  Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy     Volume:  16     ISSN:  1744-9987     ISO Abbreviation:  Ther Apher Dial     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-03-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101181252     Medline TA:  Ther Apher Dial     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  169-72     Citation Subset:  IM    
Copyright Information:
© 2012 The Authors. Therapeutic Apheresis and Dialysis © 2012 International Society for Apheresis.
Affiliation:
Departments of Nephrology and Hypertension Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Renal replacement therapy in cardiology wards: changing trends in a transitional country.
Next Document:  Effects of peripheral blood mononuclear cells morphology on vascular calcification in uremic patient...